AI-generated analysis. Always verify with the original filing.
Arbutus Biopharma Corporation filed an 8-K on February 20, 2026, disclosing a memorandum and order issued by the U.S. District Court for the District of Delaware on February 17, 2026, in litigation filed by Arbutus Biopharma. Exhibit 99.1 contains the court document.
Event Type
Disclosure
Voluntary
Variant
8-K
. Other Events. On February 17, 2026, the U.S. District Court for the District of Delaware issued a memorandum and order in the litigation filed by Arbutus Biop
. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 U.S. District Court for the District of Delaware Memorandum and Order, dated